Trial Profile
Effects of quetiapine on ultrastructural hippocampal and neurochemical changes in patients with bipolar disorder: searching for the antidepressant and mood stabilising neurophysiology.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar disorders
- Focus Adverse reactions; Pharmacodynamics
- 12 Mar 2012 Actual end date (Dec 2010) added as reported by ClinicalTrials.gov.
- 12 Mar 2012 Actual patient number (33) added as reported by ClinicalTrials.gov.
- 12 Mar 2012 Additional lead trial investigator identified as reported by ClinicalTrials.gov.